Spyre Therapeutics SYRE
NASDAQ SYRE
$87.31 +0.06 (+0.07%)
As of: Sep 4, 2026 · 1:33 PM EDT

Spyre Therapeutics (SYRE) Preferred Dividend Payments (2015)

Spyre Therapeutics' (SYRE) quarterly Preferred Dividend Payments came in at $228000.0 in Q1 2015.

Analysis

Spyre Therapeutics (SYRE) Preferred Dividend Payments (2015) Analysis & Trends

Spyre Therapeutics (SYRE) has 1 years of Preferred Dividend Payments data on file, last reported at $228000.0 in Q1 2015.

  • Quarterly Preferred Dividend Payments changed N/A year-over-year to $228000.0 in Q1 2015, while the trailing twelve-month figure through Dec 2015 was $228000.0 (changed N/A YoY) and the FY2015 annual result came in at $228000.0, changed N/A from the prior year.
  • Preferred Dividend Payments held at $228000.0 in Q1 2015.
  • In the past five years, Preferred Dividend Payments ranged from a high of $228000.0 in Q1 2015 to a low of $228000.0 in Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn -
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -
10 Spyre Therapeutics 7.40 Bn 7.40 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 228,000.00